Table 2.
Entrez gene symbol | Entrez gene name | IFN probe set ID | Fold change | CANDLE probe set ID | Fold change | Genes removed |
---|---|---|---|---|---|---|
Upregulated genesa | ||||||
>2 × increased in CANDLE | ||||||
AIM2 | Absent in melanoma 2 | 206513_at | 5.77 | x | ||
APOL1 | Apolipoprotein L, 1 | 209546_s_at | 2.26 | x | ||
APOL6 | Apolipoprotein L, 6 | 219716_at | 3.44 | 241869_at | 5.02 | |
BCL2L1 | BCL2-like 1 | 206665_s_at | 2.25 | 215037_s_at | 3.80 | |
BIRC5 | Baculoviral IAP repeat-containing 5 | 202094_at | −2.66 | 202095_s_at | 3.70 | x |
C1QB | Complement component 1, q subcomponent, B chain | 202953_at | 2.16 | x | ||
CASP1 | Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 1552703_s_at | 2.96 | x | ||
CCNA1 | Cyclin A1 | 205899_at | 7.71 | x | ||
CCNA2 | Cyclin A2 | 203418_at | 2.85 | 203418_at | 2.19 | x |
CCRL2 | Chemokine (C-C motif) receptor-like 2 | 211434_s_at | 2.36 | x | ||
CD274 | CD274 molecule | 223834_at | 6.70 | 227458_at | 3.81 | |
CD80 | CD80 molecule | 1554519_at | 2.05 | x | ||
CLTCL1 | Clathrin, heavy chain-like 1 | 205944_s_at | 2.80 | x | ||
CXCL10 | Chemokine (C-X-C motif) ligand 10 | 204533_at | 12.92 | 204533_at | 4.03 | |
DDX58 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 | 218943_s_at | 4.65 | 242961_x_at | 6.53 | |
DDX60 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 | 218986_s_at | 2.00 | 218986_s_at | 4.60 | |
EIF2AK2 | Eukaryotic translation initiation factor 2-alpha kinase 2 | 204211_x_at | 2.53 | 204211_x_at | 2.72 | |
FCGR1A | Fc fragment of IgG, high-affinity Ia, receptor (CD64) | 216951_at | 2.13 | 216951_at | 5.22 | |
FCGR1B | Fc fragment of IgG, high-affinity Ib, receptor (CD64) | 214511_x_at | 4.34 | x | ||
GBP1 | Guanylate-binding protein 1, interferon-inducible | 202269_x_at | 4.85 | 231578_at | 4.45 | |
GBP2 | Guanylate-binding protein 2, interferon-inducible | 242907_at | 2.01 | x | ||
H6PD | Hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) | 226160_at | 2.28 | x | ||
HERC5 | Hect domain and RLD 5 | 219863_at | 5.56 | 219863_at | 6.50 | |
HERC6 | Hect domain and RLD 6 | 219352_at | 2.23 | 219352_at | 4.63 | |
IFI27 | Interferon alpha-inducible protein 27 | 202411_at | 2.28 | 202411_at | 72.76 | |
IFI35 | Interferon-induced protein 35 | 209417_s_at | 3.51 | 209417_s_at | 2.80 | |
IFI44 | Interferon-induced protein 44 | 214059_at | 4.01 | 214059_at | 9.41 | |
IFI44L | Interferon-induced protein 44-like | 204439_at | 2.94 | 204439_at | 13.36 | |
IFI6 | Interferon alpha-inducible protein 6 | 204415_at | 6.22 | 204415_at | 3.94 | |
IFIH1 | Interferon induced with helicase C domain 1 | 216020_at | 4.41 | 1555464_at | 3.52 | |
IFIT1 | Interferon-induced protein with tetratricopeptide repeats 1 | 203153_at | 5.85 | 203153_at | 8.68 | |
IFIT2 | Interferon-induced protein with tetratricopeptide repeats 2 | 217502_at | 31.77 | 217502_at | 2.52 | |
IFIT3 | Interferon-induced protein with tetratricopeptide repeats 3 | 204747_at | 11.11 | 204747_at | 7.16 | |
IFIT5 | Interferon-induced protein with tetratricopeptide repeats 5 | 203595_s_at | 2.96 | 203596_s_at | 3.63 | |
IGLL1/IGLL5 | Immunoglobulin lambda-like polypeptide 1 | 217235_x_at | 2.15 | x | ||
IL10 | Interleukin 10 | 207433_at | 2.18 | x | ||
IL15 | Interleukin 15 | 205992_s_at | 2.52 | x | ||
IL18R1 | Interleukin 18 receptor 1 | 206618_at | 2.67 | x | ||
IL1RN | Interleukin 1 receptor antagonist | 212657_s_at | 2.45 | 216243_s_at | 2.43 | |
IRF7 | Interferon regulatory factor 7 | 208436_s_at | 2.19 | 208436_s_at | 3.09 | |
ISG15 | ISG15 ubiquitin-like modifier | 205483_s_at | 7.20 | 205483_s_at | 7.05 | |
LAMP3 | Lysosomal-associated membrane protein 3 | 205569_at | 4.99 | 205569_at | 4.24 | |
LGALS3BP | Lectin, galactoside-binding, soluble, 3-binding protein | 200923_at | 5.39 | x | ||
LY6E | Lymphocyte antigen 6 complex, locus E | 202145_at | 3.08 | 202145_at | 6.19 | |
MMP1 | Matrix metallopeptidase 1 (interstitial collagenase) | 204475_at | 4.25 | x | ||
MMP9 | Matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | 203936_s_at | 3.27 | 203936_s_at | 3.53 | x |
MTMR3 | Myotubularin-related protein 3 | 202198_s_at | 2.33 | x | ||
MUC1 | Mucin 1, cell surface-associated | 213693_s_at | 2.84 | x | ||
MX1 | Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | 202086_at | 4.19 | 202086_at | 5.53 | |
NF1 | Neurofibromin 1 | 204323_x_at | 2.31 | 216115_at | 3.00 | |
OAS1 | 2′-5′-Oligoadenylate synthetase 1, 40/46 kDa | 202869_at | 2.12 | 205552_s_at | 8.06 | |
OAS2 | 2′-5′-Oligoadenylate synthetase 2, 69/71 kDa | 204972_at | 2.22 | 228607_at | 4.26 | |
OAS3 | 2′-5′-Oligoadenylate synthetase 3, 100 kDa | 218400_at | 2.66 | 218400_at | 9.20 | |
OASL | 2′-5′-Oligoadenylate synthetase-like | 205660_at | 6.72 | 210797_s_at | 5.44 | |
PLSCR1 | Phospholipid scramblase 1 | 202430_s_at | 2.51 | 202446_s_at | 3.65 | |
PML | Promyelocytic leukemia | 206503_x_at | 2.57 | 211012_s_at | 3.07 | |
PRDX2 | Peroxiredoxin 2 | 211658_at | 2.05 | x | ||
RBX1 | Ring-box 1, E3 ubiquitin protein ligase | 218117_at | 2.64 | x | ||
RSAD2 | Radical S-adenosyl methionine domain-containing 2 | 213797_at | 4.39 | 213797_at | 12.91 | |
RTP4 | Receptor (chemosensory) transporter protein 4 | 219684_at | 3.20 | 219684_at | 5.05 | |
SAMD9 | Sterile alpha motif domain-containing 9 | 219691_at | 3.00 | 219691_at | 3.00 | |
SEPT4 | Septin 4 | 210657_s_at | 7.52 | x | ||
SOCS1 | Suppressor of cytokine signaling 1 | 210001_s_at | 5.65 | 210001_s_at | 2.13 | |
STAT1 | Signal transducer and activator of transcription 1, 91 kDa | AFFX-HUMISGF3A/M97935_5_at | 2.07 | AFFX-HUMISGF3A/M97935_MA_at | 3.25 | |
STAT2 | Signal transducer and activator of transcription 2, 113 kDa | 205170_at | 2.45 | 205170_at | 2.18 | |
TAP2 | Transporter 2, ATP-binding cassette, subfamily B (MDR/TAP) | 208428_at | 3.89 | x | ||
TDRD7 | Tudor domain-containing 7 | 213361_at | 2.73 | 213361_at | 2.05 | |
USP18 | Ubiquitin-specific peptidase 18 | 219211_at | 12.11 | 219211_at | 13.86 | |
USP6NL | USP6N terminal-like | 238164_at | 4.61 | x | ||
ZC3HAV1 | Zinc finger CCCH-type, antiviral 1 | 213051_at | 2.14 | 220104_at | 2.33 | |
>2 × increased in IFN probe set, but not increased in CANDLE | ||||||
ATF3 | Activating transcription factor 3 | 202672_s_at | 9.33 | |||
BST2 | Bone marrow stromal cell antigen 2 | 201641_at | 2.25 | |||
CCL2 | Chemokine (C-C motif) ligand 2 | 216598_s_at | 45.74 | x | ||
DEFB1 | Defensin beta 1 | 210397_at | 3.98 | x | ||
FAS | Fas (TNF receptor superfamily, member 6) | 215719_x_at | 2.75 | |||
HSH2D | Hematopoietic SH2 domain-containing | 1552623_at | 3.68 | x | ||
IDO1 | Indoleamine 2,3-dioxygenase 1 | 210029_at | 2.39 | |||
IL1B | Interleukin 1, beta | 205067_at | 3.58 | |||
IRF1 | Interferon regulatory factor 1 | 202531_at | 2.16 | |||
IRF2 | Interferon regulatory factor 2 | 203275_at | 2.25 | x | ||
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 204626_s_at | 2.03 | |||
KLF6 | Kruppel-like factor 6 | 208960_s_at | 2.72 | |||
MDM2 | Mdm2 p53-binding protein homolog (mouse) | 211832_s_at | 2.28 | |||
MX2 | Myxovirus (influenza virus) resistance 2 (mouse) | 204994_at | 2.13 | |||
PELI1 | Pellino E3 ubiquitin protein ligase 1 | 218319_at | 2.21 | |||
PRKCD | Protein kinase C delta | 202545_at | 2.16 | x | ||
PRKD2 | Protein kinase D2 | 209282_at | 2.28 | |||
PTAFR | Platelet-activating factor receptor | 206278_at | 3.22 | |||
PTGES | Prostaglandin E synthase | 210367_s_at | 2.58 | |||
SOD2 | Superoxide dismutase 2, mitochondrial | 215078_at | 2.41 | |||
SP100 | SP100 nuclear antigen | 202864_s_at | 2.22 | |||
SP110 | SP110 nuclear body protein | 208392_x_at | 3.47 | |||
SPI1 | Spi-1 proto-oncogene | 205312_at | 2.54 | |||
TLR4 | Toll-like receptor 4 | 221060_s_at | 2.10 | |||
TNFRSF1A | TNF receptor superfamily member 1A | 207643_s_at | 2.05 | |||
TNFSF10 | TNF superfamily member 10 | 202687_s_at | 2.39 | |||
TNFSF13B | TNF superfamily member 13b | 223502_s_at | 2.47 | |||
TREX1 | Three prime repair exonuclease 1 | 205875_s_at | 3.56 | |||
TRIM14 | Tripartite motif-containing 14 | 203147_s_at | 2.45 | |||
TYMP | Thymidine phosphorylase | 217497_at | 4.08 | |||
Downregulated genesb | ||||||
>2 × decreased in CANDLE | ||||||
ADORA2B | Adenosine A2b receptor | 205891_at | −2.55 | x | ||
ALOX15 | Arachidonate 15-lipoxygenase | 207328_at | −4.15 | |||
AUTS2 | Autism susceptibility candidate 2 | 212599_at | −3.65 | x | ||
CAMK4 | Calcium/calmodulin-dependent protein kinase IV | 241871_at | −3.27 | x | ||
CCL5 | Chemokine (C-C motif) ligand 5 | 204655_at | −2.11 | |||
CCR5 | Chemokine (C-C motif) receptor 5 | 206991_s_at | −2.39 | x | ||
CD2 | CD2 molecule | 205831_at | −2.74 | x | ||
CD40LG | CD40 ligand | 207892_at | −4.33 | x | ||
CIITA | Class II, major histocompatibility complex, transactivator | 205101_at | −2.26 | |||
CXCL1 | Chemokine (C-X-C motif) ligand 1 (melanoma growth-stimulating activity, alpha) | 204470_at | −2.40 | |||
CXCR3 | Chemokine (C-X-C motif) receptor 3 | 207681_at | −2.03 | |||
DPP4 | Dipeptidyl-peptidase 4 | 203717_at | −2.28 | x | ||
EEF1A1 | Eukaryotic translation elongation factor 1 alpha 1 | 227708_at | −2.27 | x | ||
GATA3 | GATA-binding protein 3 | 209604_s_at | −3.17 | x | ||
HLA-DQB1 | Major histocompatibility complex, class II, DQ beta 1 | 212999_x_at | −3.53 | x | ||
IL23A | Interleukin 23, alpha subunit p19 | 240102_at | −3.08 | x | ||
IL24 | Interleukin 24 | 206569_at | −2.13 | |||
IL32 | Interleukin 32 | 203828_s_at | −2.31 | |||
IL8 | Interleukin 8 | 202859_x_at | −2.40 | 202859_x_at | −5.24 | |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | 1555691_a_at | −2.61 | x | ||
MARCKSL1 | MARCKS-like 1 | 200644_at | −2.58 | x | ||
NCR3 | Natural cytotoxicity-triggering receptor 3 | 211583_x_at | −3.11 | x | ||
PIGR | Polymeric immunoglobulin receptor | 226147_s_at | −2.03 | x | ||
PTGS2 | Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 1554997_a_at | 2.82 | 1554997_a_at | −4.94 | x |
TBX21 | T-box 21 | 220684_at | −2.14 | x | ||
>2 × decreased in IFN probe set, but not increased in CANDLE | ||||||
CCDC75 | Coiled-coil domain-containing 75 | 228495_at | −2.30 | |||
CXCL2 | Chemokine (C-X-C motif) ligand 2 | 209774_x_at | −2.88 | |||
ELAVL1 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 1 (Hu antigen R) | 244660_at | −5.24 | x | ||
ICOSLG | Inducible T cell costimulator ligand | 213450_s_at | −2.36 | x | ||
ITGAV | Integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 202351_at | −2.17 | x | ||
PARVG | Parvin, gamma | 244229_at | −2.20 | |||
TLR3 | Toll-like receptor 3 | 206271_at | −2.04 | |||
Added later for initial NanoString IRG listc | ||||||
C1QC | Complement component 1, q subcomponent, C chain | x | ||||
CEACAM1 | Carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | x | ||||
CYSLTR2 | Cysteinyl leukotriene receptor 2 | x | ||||
IGFBP4 | Insulin-like growth factor-binding protein 4 | x | ||||
IRF3 | Interferon regulatory factor 3 | x | ||||
IFN and IFNR genesd | ||||||
IFNA1 | Interferon, alpha 1 | 208375_at | x | |||
IFNA10 | Interferon alpha 10 | 208261_x_at | x | |||
IFNA16 | Interferon alpha 16 | 208448_x_at | x | |||
IFNA2 | Interferon alpha 2 | 211338_at | ||||
IFNA21 | Interferon, alpha 21 | 211145_x_at | x | |||
IFNA5 | Interferon alpha 5 | 214569_at | x | |||
IFNA6 | Interferon alpha 6 | 208548_at | x | |||
IFNA7 | Interferon, alpha 7 | 208259_x_at | x | |||
IFNA8 | Interferon alpha 8 | 207932_at | x | |||
IFNAR1 | Interferon alpha and beta receptor subunit 1 | 204191_at | ||||
IFNAR2 | Interferon (alpha, beta, and omega) receptor 2 | 204785_x_at | ||||
IFNB1 | Interferon, beta 1, fibroblast | 208173_at | ||||
IFNG | Interferon, gamma | 210354_at | ||||
IFNGR1 | Interferon gamma receptor 1 | 202727_s_at | ||||
IFNGR2 | Interferon gamma receptor 2 | 201642_at | ||||
Housekeeping genese | ||||||
ALAS1 | Delta-aminolevulinate synthase 1 | |||||
G6PD | Glucose-6-phosphate dehydrogenase | x | ||||
HPRT1 | Hypoxanthine phosphoribosyltransferase 1 | |||||
POLR2A | RNA polymerase II subunit A | x | ||||
TBP | TATA box-binding protein | |||||
TUBB | Tubulin beta class I |
Increased expression versus HCs potential IFN target genes.
Decreased expression versus HCs IFN target genes.
Added afterwards.
IFN or IFNR gene added.
Housekeeping gene.
This list of genes is based on previous microarray data from an IFN-alpha-treated hepatitis patient and 1 CANDLE patient at multiple time points with microarray probe set ID and fold change comprising the initial 152 candidate gene list and 6 housekeeping genes. Genes have been grouped alphabetically within each category as described. In the right-most column, x indicates genes removed from initial candidate list to get to target gene list 2, which has 92 IRS genes and 4 housekeeping genes.
IFN, interferon; IRG, IFN response gene; IRS, IFN-regulated gene signature.